Document is current

Article History

Accepted: 28 April 2024

First Online: 31 July 2024

Declarations

:

: This study was funded by Janssen Scientific Affairs, LLC, a Johnson & Johnson company. Authors who are employees of the study sponsor were involved in several aspects of the research, including designing the study. All authors were involved in interpretation of data and drafting or revising the writing of the manuscript.

: IL, NS, and SDC are employees of Janssen Scientific Affairs, LLC, a Johnson & Johnson company and stockholders of Johnson & Johnson. NS received salary support from the Childhood Arthritis and Rheumatology Research Alliance and owns or has owned stock in AbbVie, Gilead, Iovance, Jazz Pharmaceuticals, Novavax, and Viatris. RZ was an employee of Janssen Scientific Affairs, LLC, a Johnson & Johnson company at the time of study conduct. PL, DP, BE, LM, LHY, and SS are employees of Analysis Group, Inc., a consulting company that has received research funding from Janssen Scientific Affairs, LLC, a Johnson & Johnson company. JAW received research funding from Pfizer, Merck, AbbVie and served as a consultant for AbbVie, Janssen, Eli Lilly, Novartis, UCB. PM received research funding from AbbVie, Acelyrin, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, Sun Pharma, and UCB, served as a consultant for AbbVie, Acelyrin, Aclaris, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Galapagos, Gilead, GlaxoSmithKline, Inmagene, Janssen, Novartis, Pfizer, Sun Pharma, UCB, and Ventyx, and received speaker fees from AbbVie, Amgen, Eli Lilly, Janssen, Novartis, Pfizer, and UCB.

: JAW contributed to the conceptualization, investigation, methodology, supervision, validation, visualization, writing of the original draft, and its review and editing. IL contributed to the conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization, writing of the original draft, and its review and editing. RZ contributed to the conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization, writing of the original draft, and its review and editing. NJS contributed to the conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization, writing of the original draft, and its review and editing. LM contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. BE contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. LHY contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. SS contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. PL contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. DP contributed to the conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, software, supervision, validation, visualization, writing of the original draft, and its review and editing. SDC contributed to the conceptualization, funding acquisition, investigation, methodology, project administration, resources, supervision, validation, visualization, writing of the original draft, and its review and editing. PM contributed to the conceptualization, investigation, methodology, supervision, validation, visualization, writing of the original draft, and its review and editing. All authors have reviewed and approved the final submitted manuscript and agree to be accountable for all aspects of the work.

: The data that support the findings of this study are available from IQVIA PharMetrics^® Plus. Restrictions apply to the availability of these data, which were used under license for this study.

: Data were de-identified and comply with the patient requirements of the Health Insurance Portability and Accountability Act (HIPAA) of 1996; therefore, no review by an Institutional Review Board was required per Title 45 of CFR, Part 46.101(b)(4) ().

: Not applicable.

: Not applicable.

: All analyses were conducted using SAS Enterprise Guide 7.1 (SAS Institute, Cary, NC, US). The SAS programs are proprietary materials of Analysis Group, Inc.; therefore, restrictions apply to the access of these codes, which cannot be made available publicly.